Surprisingly, we detected a significantly low incidence of BRAF mutation, both in adenomas (2%) and in CRC (0.7%), and a relatively low incidence of KRAS mutation (24.9%) compared with that in other populations [9, 10, 29, 32, 33, 39, 40]. Here, BRAF is linked to colorectal carcinoma.